Ken Griffin Magenta Therapeutics, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.62 - $0.79 $2.08 Million - $2.65 Million	3,351,181 Added 37995.25%	3,360,001 $2.55 Million
Q1 2023 May 15, 2023	BUY	$0.41 - $0.86 $407 - $854	994 Added 12.7%	8,820 $6,000
Q4 2022 Feb 14, 2023	SELL	$0.36 - $1.59 $11,675 - $51,568	-32,433 Reduced 80.56%	7,826 $3,000
Q3 2022 Nov 14, 2022	BUY	$1.26 - $2.09 $50,726 - $84,141	40,259 New	40,259 $56,000
Q2 2022 Aug 15, 2022	SELL	$0.97 - $3.08 $135,800 - $431,203	-140,001 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.55 - $5.23 $4,421 - $9,068	1,734 Added 1.25%	140,001 $406,000
Q2 2021 Aug 16, 2021	SELL	$9.76 - $14.15 $6.22 Million - $9.02 Million	-637,147 Reduced 82.17%	138,267 $1.35 Million
Q1 2021 May 17, 2021	BUY	$7.66 - $13.38 $5.17 Million - $9.03 Million	674,793 Added 670.63%	775,414 $9.18 Million
Q4 2020 Feb 16, 2021	BUY	$6.1 - $7.94 $159,454 - $207,551	26,140 Added 35.1%	100,621 $789,000
Q3 2020 Nov 16, 2020	SELL	$6.52 - $8.94 $78,755 - $107,986	-12,079 Reduced 13.95%	74,481 $506,000
Q2 2020 Aug 14, 2020	SELL	$6.18 - $10.76 $140,533 - $244,682	-22,740 Reduced 20.81%	86,560 $650,000
Q1 2020 May 15, 2020	BUY	$6.03 - $15.24 $129,337 - $326,882	21,449 Added 24.42%	109,300 $686,000
Q4 2019 Feb 14, 2020	SELL	$9.07 - $15.84 $840,389 - $1.47 Million	-92,656 Reduced 51.33%	87,851 $1.33 Million
Q3 2019 Nov 14, 2019	SELL	$9.63 - $14.0 $467,623 - $679,826	-48,559 Reduced 21.2%	180,507 $1.85 Million
Q2 2019 Aug 14, 2019	BUY	$13.4 - $17.67 $734,949 - $969,146	54,847 Added 31.48%	229,066 $3.38 Million
Q1 2019 May 15, 2019	BUY	$5.7 - $19.7 $870,549 - $3.01 Million	152,728 Added 710.66%	174,219 $0
Q4 2018 Feb 14, 2019	SELL	$5.57 - $11.65 $363,798 - $760,908	-65,314 Reduced 75.24%	21,491 $122,000
Q2 2018 Aug 10, 2018	BUY	$13.5 - $14.52 $1.17 Million - $1.26 Million	86,805 New	86,805 $0

Others Institutions Holding MGTA

# of Institutions

Shares Held

442K

Call Options Held

Put Options Held

Hellman Jordan Management CO Inc Quincy, MA

441K
Shares

$0
0.3% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.3K
Shares

$0
0.0% of portfolio

View Full List

About Magenta Therapeutics, Inc.

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

More about MGTA

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account